BE702023A - - Google Patents

Info

Publication number
BE702023A
BE702023A BE702023DA BE702023A BE 702023 A BE702023 A BE 702023A BE 702023D A BE702023D A BE 702023DA BE 702023 A BE702023 A BE 702023A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE702023A publication Critical patent/BE702023A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE702023D 1966-07-29 1967-07-28 BE702023A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3427566 1966-07-29
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
BE702023A true BE702023A (enrdf_load_stackoverflow) 1968-01-29

Family

ID=26256295

Family Applications (1)

Application Number Title Priority Date Filing Date
BE702023D BE702023A (enrdf_load_stackoverflow) 1966-07-29 1967-07-28

Country Status (12)

Country Link
JP (2) JPS5021469B1 (enrdf_load_stackoverflow)
AT (2) AT311564B (enrdf_load_stackoverflow)
BE (1) BE702023A (enrdf_load_stackoverflow)
CH (2) CH580644A5 (enrdf_load_stackoverflow)
DE (1) DE1668124B2 (enrdf_load_stackoverflow)
DK (2) DK129004B (enrdf_load_stackoverflow)
FR (2) FR1565340A (enrdf_load_stackoverflow)
GB (1) GB1202521A (enrdf_load_stackoverflow)
IL (1) IL28411A (enrdf_load_stackoverflow)
NL (1) NL6710459A (enrdf_load_stackoverflow)
PL (1) PL79253B1 (enrdf_load_stackoverflow)
SE (2) SE349025B (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034479A1 (enrdf_load_stackoverflow) * 1969-01-23 1970-12-11 Glaxo Lab Ltd
FR2059570A1 (enrdf_load_stackoverflow) * 1969-07-25 1971-06-04 Glaxo Lab Ltd

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5090183A (enrdf_load_stackoverflow) * 1973-12-14 1975-07-19
JPS5090184A (enrdf_load_stackoverflow) * 1973-12-14 1975-07-19

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034479A1 (enrdf_load_stackoverflow) * 1969-01-23 1970-12-11 Glaxo Lab Ltd
FR2059570A1 (enrdf_load_stackoverflow) * 1969-07-25 1971-06-04 Glaxo Lab Ltd

Also Published As

Publication number Publication date
DE1668124B2 (de) 1976-10-07
DK131295C (enrdf_load_stackoverflow) 1975-11-17
FR7812M (enrdf_load_stackoverflow) 1970-05-20
CH584724A5 (enrdf_load_stackoverflow) 1977-02-15
AT301766B (de) 1972-09-25
FR1565340A (enrdf_load_stackoverflow) 1969-05-02
GB1202521A (en) 1970-08-19
IL28411A (en) 1972-07-26
SE350488B (enrdf_load_stackoverflow) 1972-10-30
NL6710459A (enrdf_load_stackoverflow) 1968-01-30
SE349025B (enrdf_load_stackoverflow) 1972-09-18
DE1668124A1 (de) 1971-05-06
JPS5224013B1 (enrdf_load_stackoverflow) 1977-06-28
AT311564B (de) 1973-11-26
DK129004B (da) 1974-08-05
PL79253B1 (enrdf_load_stackoverflow) 1975-06-30
DK131295B (da) 1975-06-23
CH580644A5 (enrdf_load_stackoverflow) 1976-10-15
JPS5021469B1 (enrdf_load_stackoverflow) 1975-07-23

Similar Documents

Publication Publication Date Title
AU5917865A (enrdf_load_stackoverflow)
AU428063B2 (enrdf_load_stackoverflow)
AU424443B2 (enrdf_load_stackoverflow)
AU414526B2 (enrdf_load_stackoverflow)
AU433222B2 (enrdf_load_stackoverflow)
AU421822B2 (enrdf_load_stackoverflow)
AU417216B2 (enrdf_load_stackoverflow)
AU415165B1 (enrdf_load_stackoverflow)
AU1144366A (enrdf_load_stackoverflow)
AU6703465A (enrdf_load_stackoverflow)
AU612166A (enrdf_load_stackoverflow)
AU5895065A (enrdf_load_stackoverflow)
AU1111066A (enrdf_load_stackoverflow)
AU218666A (enrdf_load_stackoverflow)
BE284991A (enrdf_load_stackoverflow)
BE597652A (enrdf_load_stackoverflow)
AU433620A (enrdf_load_stackoverflow)
AU415780B2 (enrdf_load_stackoverflow)
AU411645B2 (enrdf_load_stackoverflow)
AU407778B2 (enrdf_load_stackoverflow)
BE692112A (enrdf_load_stackoverflow)
BE692360A (enrdf_load_stackoverflow)
AU6852465A (enrdf_load_stackoverflow)
AU855865A (enrdf_load_stackoverflow)
AU92366A (enrdf_load_stackoverflow)